Form 8-K - Current report:
SEC Accession No. 0001213900-25-059970
Filing Date
2025-07-01
Accepted
2025-07-01 08:10:34
Documents
14
Period of Report
2025-07-01
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea0247672-8k_180life.htm   iXBRL 8-K 32246
2 PRESS RELEASE DATED JULY 1, 2025 ea024767201ex99-1_180life.htm EX-99.1 15753
  Complete submission text file 0001213900-25-059970.txt   266403

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE atnf-20250701.xsd EX-101.SCH 3786
4 XBRL DEFINITION FILE atnf-20250701_def.xml EX-101.DEF 26628
5 XBRL LABEL FILE atnf-20250701_lab.xml EX-101.LAB 36679
6 XBRL PRESENTATION FILE atnf-20250701_pre.xml EX-101.PRE 25252
16 EXTRACTED XBRL INSTANCE DOCUMENT ea0247672-8k_180life_htm.xml XML 5810
Mailing Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306
Business Address 3000 EL CAMINO REAL BLDG 4, STE 200 PALO ALTO CA 94306 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 251094208
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)